ATE311884T1 - Cyclin-abhängige-kinase inhibierende purinderivate - Google Patents
Cyclin-abhängige-kinase inhibierende purinderivateInfo
- Publication number
- ATE311884T1 ATE311884T1 AT98932413T AT98932413T ATE311884T1 AT E311884 T1 ATE311884 T1 AT E311884T1 AT 98932413 T AT98932413 T AT 98932413T AT 98932413 T AT98932413 T AT 98932413T AT E311884 T1 ATE311884 T1 AT E311884T1
- Authority
- AT
- Austria
- Prior art keywords
- dependent kinase
- cyclin dependent
- purine derivatives
- kinase inhibiting
- inhibiting purine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714603.9A GB9714603D0 (en) | 1997-07-12 | 1997-07-12 | Cyclin dependent kinase inhibitors |
GBGB9806743.2A GB9806743D0 (en) | 1998-03-28 | 1998-03-28 | Cyclin dependent kinase inhibitors |
PCT/GB1998/002025 WO1999002162A1 (en) | 1997-07-12 | 1998-07-10 | Cyclin dependent kinase inhibiting purine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE311884T1 true ATE311884T1 (de) | 2005-12-15 |
Family
ID=26311867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98932413T ATE311884T1 (de) | 1997-07-12 | 1998-07-10 | Cyclin-abhängige-kinase inhibierende purinderivate |
Country Status (9)
Country | Link |
---|---|
US (1) | US6303618B1 (de) |
EP (1) | EP1017394B1 (de) |
JP (1) | JP2001509483A (de) |
AT (1) | ATE311884T1 (de) |
AU (1) | AU744986B2 (de) |
CA (1) | CA2294244A1 (de) |
DE (1) | DE69832715T2 (de) |
ES (1) | ES2253821T3 (de) |
WO (1) | WO1999002162A1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
HN2001000008A (es) | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
EP1274706A1 (de) | 2000-04-18 | 2003-01-15 | Agouron Pharmaceuticals, Inc. | Pyrazole zur inhibierung von proteinkinasen |
WO2001082967A1 (en) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | MEDICINAL COMPOSITIONS FOR SUPPRESSING β-AMYLOID PRODUCTION |
KR100423899B1 (ko) * | 2000-05-10 | 2004-03-24 | 주식회사 엘지생명과학 | 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸 |
MXPA03001189A (es) | 2000-08-09 | 2004-05-14 | Agouron Pharma | Compuestos de pirazol-tiazol, composiciones farmaceuticas que los contienen y su uso para inhibir las cinasas dependientes de ciclinas. |
DE60110802T2 (de) | 2000-08-18 | 2005-10-06 | Agouron Pharmaceuticals, Inc., San Diego | Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen |
WO2002050079A1 (fr) * | 2000-12-20 | 2002-06-27 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3) |
FR2818278B1 (fr) * | 2000-12-20 | 2003-02-28 | Sod Conseils Rech Applic | Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3) |
GB0101686D0 (en) * | 2001-01-23 | 2001-03-07 | Cancer Res Campaign Tech | Cyclin dependent kinase inhibitors |
AU2002343604C1 (en) | 2001-10-30 | 2009-09-17 | Conforma Therapeutics Corporation | Purine analogs having HSP90-inhibiting activity |
US7288547B2 (en) | 2002-03-11 | 2007-10-30 | Schering Ag | CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
EP1444982A1 (de) * | 2003-02-06 | 2004-08-11 | Merckle Gmbh | Verwendung von Purinderivaten als selektive Kinase-Inhibitoren |
CN101906106A (zh) | 2003-09-18 | 2010-12-08 | 康福玛医药公司 | 作为hsp90-抑制剂的新的杂环化合物 |
CA2541989C (en) * | 2003-10-24 | 2013-10-01 | Exelixis, Inc. | P70s6 kinase modulators and method of use |
EP1746889B1 (de) * | 2004-05-12 | 2009-07-22 | Bayer CropScience AG | Regulation des pflanzenwachstums |
EP1765313A2 (de) | 2004-06-24 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Verbindungen als immunstimulatoren |
FR2880626B1 (fr) * | 2005-01-13 | 2008-04-18 | Aventis Pharma Sa | Derives de la purine, compositions les contenant et utilisation |
GB0502573D0 (en) * | 2005-02-08 | 2005-03-16 | Topotarget As | Therapeutic compounds |
US7544672B2 (en) | 2005-03-30 | 2009-06-09 | Conforma Therapeutics Corporation | Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors |
US20070110751A1 (en) * | 2005-10-25 | 2007-05-17 | Maclellan Robb | Compositions and methods for reducing infarct size |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
TW200808739A (en) | 2006-04-06 | 2008-02-16 | Novartis Vaccines & Diagnostic | Quinazolines for PDK1 inhibition |
ES2437595T3 (es) | 2007-12-20 | 2014-01-13 | Novartis Ag | Derivados de tiazol usados como inhibidores de la PI 3 quinasa |
EP2179993A1 (de) | 2008-10-21 | 2010-04-28 | Bayer Schering Pharma Aktiengesellschaft | Sulfoxidsubstituierte Anilinopyrimidinderivative als CDK-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
EP2179992A1 (de) | 2008-10-21 | 2010-04-28 | Bayer Schering Pharma Aktiengesellschaft | Sulfonsubstituierte Anlinopyrimidinderivative als CDK-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
EP2179991A1 (de) | 2008-10-21 | 2010-04-28 | Bayer Schering Pharma Aktiengesellschaft | Sulfoximinsubstituierte Anilino-Pyrimidinderivate als CDK-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
DE102009001438A1 (de) | 2009-03-10 | 2010-09-16 | Bayer Schering Pharma Aktiengesellschaft | Carbonylamino-substituierte Anilino-Pyrimidinderivate als Tyk-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
DE102009015070A1 (de) | 2009-03-30 | 2010-10-14 | Bayer Schering Pharma Aktiengesellschaft | Aminocabonylamino-substituierte Anilino-Pyrimidinderivate als Tyk-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
DE102010014426A1 (de) | 2010-04-01 | 2011-10-06 | Bayer Schering Pharma Aktiengesellschaft | Verwendung neuer pan-CDK-Inhibitoren zur Behandlung von Tumoren |
DE102010014427A1 (de) | 2010-04-01 | 2011-10-06 | Bayer Schering Pharma Aktiengesellschaft | Kombinationen neuer pan-CDK-Inhibitoren zur Behandlung von Tumoren |
AR082418A1 (es) | 2010-08-02 | 2012-12-05 | Novartis Ag | Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico |
WO2012078559A2 (en) | 2010-12-07 | 2012-06-14 | Yale University | Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same |
US8987257B2 (en) | 2011-01-31 | 2015-03-24 | Novartis Ag | Heterocyclic derivatives |
MX340452B (es) | 2011-10-28 | 2016-07-08 | Novartis Ag | Novedosos derivados de purina y su uso en el tratamiento de enfermedades. |
AR089284A1 (es) * | 2011-12-22 | 2014-08-13 | Galapagos Nv | Dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de trastornos inflamatorios |
EA201491732A1 (ru) | 2012-03-21 | 2015-08-31 | Байер Интеллектуэль Проперти Гмбх | Применение (rs)-s-циклопропил-s-(4-{[4-{[(1r,2r)-2-гидрокси-1-метилпропил]окси}-5-(трифторметил)пиримидин-2-ил]амино}фенил)сульфоксимида для лечения специфических опухолей |
KR20150009540A (ko) | 2012-05-16 | 2015-01-26 | 노파르티스 아게 | Pi-3 키나제 억제제에 대한 투여 요법 |
US9925193B2 (en) * | 2012-11-20 | 2018-03-27 | Proqinase Gmbh | Thioether derivatives as protein kinase inhibitors |
WO2014173815A1 (en) | 2013-04-23 | 2014-10-30 | Bayer Pharma Aktiengesellschaft | Use of (rs)-s-cyclopropyl-s-(4-{[4-{[(1r, 2r)-2-hydroxy-1-methylpropyl]oxy}-5- (trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulphoximide for the treatment of specific tumours |
GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
CN105979947A (zh) | 2013-12-06 | 2016-09-28 | 诺华股份有限公司 | α-同工型选择性磷脂酰肌醇3-激酶抑制剂的剂量方案 |
RU2018119085A (ru) | 2015-11-02 | 2019-12-04 | Новартис Аг | Схема введения ингибитора фосфатидилинозитол-3-киназы |
WO2018060833A1 (en) | 2016-09-27 | 2018-04-05 | Novartis Ag | Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876257A (en) * | 1988-03-03 | 1989-10-24 | Ortho Pharmaceutical Corporation | 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents |
NZ238122A (en) * | 1990-05-23 | 1994-01-26 | Ortho Pharma Corp | 6-substituted purinyl piperazine derivatives and pharmaceutical |
DE69433161T2 (de) * | 1993-06-08 | 2004-07-08 | Cancer Research Technology Ltd. | O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen |
US5929046A (en) * | 1994-06-08 | 1999-07-27 | Cancer Research Campaign Technology Limited | Pyrimidine and purine derivatives and their use in treating tumour cells |
US5525606A (en) * | 1994-08-01 | 1996-06-11 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
DE69613211T2 (de) * | 1995-11-14 | 2001-11-15 | Pharmacia & Upjohn Spa | Aryl- und heteroaryl- purin- und pyridopyrimidin- derivate |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
-
1998
- 1998-07-10 AT AT98932413T patent/ATE311884T1/de not_active IP Right Cessation
- 1998-07-10 EP EP98932413A patent/EP1017394B1/de not_active Expired - Lifetime
- 1998-07-10 JP JP2000501753A patent/JP2001509483A/ja active Pending
- 1998-07-10 AU AU82342/98A patent/AU744986B2/en not_active Ceased
- 1998-07-10 CA CA002294244A patent/CA2294244A1/en not_active Abandoned
- 1998-07-10 ES ES98932413T patent/ES2253821T3/es not_active Expired - Lifetime
- 1998-07-10 WO PCT/GB1998/002025 patent/WO1999002162A1/en active IP Right Grant
- 1998-07-10 DE DE69832715T patent/DE69832715T2/de not_active Expired - Fee Related
-
2000
- 2000-01-12 US US09/481,708 patent/US6303618B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2294244A1 (en) | 1999-01-21 |
DE69832715T2 (de) | 2007-01-11 |
JP2001509483A (ja) | 2001-07-24 |
AU8234298A (en) | 1999-02-08 |
AU744986B2 (en) | 2002-03-07 |
WO1999002162A9 (en) | 1999-07-29 |
US6303618B1 (en) | 2001-10-16 |
DE69832715D1 (de) | 2006-01-12 |
ES2253821T3 (es) | 2006-06-01 |
WO1999002162A1 (en) | 1999-01-21 |
EP1017394B1 (de) | 2005-12-07 |
EP1017394A1 (de) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE311884T1 (de) | Cyclin-abhängige-kinase inhibierende purinderivate | |
TR200100918T2 (tr) | Aril ve heteroaril sübstitüentli üreler kullanılarak RAF kinazın inhibe edilmesi | |
YU49101A (sh) | Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze | |
HK1031832A1 (en) | Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas | |
IL136738A0 (en) | Inhibition of p38 kinase activity using substituted heterocyclic ureas | |
ME00275B (me) | ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE | |
TR200100874T2 (tr) | Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi | |
DK0873340T3 (da) | Heterocyklisk substituerede cyclopentanforbindelser | |
AU7585498A (en) | Inhibition of p38 kinase activity by aryl ureas | |
MX9202181A (es) | Compuestos arilicos y heteroarilicos bis mono y biciclicos que inhiben la tirosina quinasa de receptor de egf y/o pdgf. | |
GEP20022786B (en) | Purine Inhibitors of Cyclin Dependent Kinase 2 and 1kB-a | |
DE69828436D1 (de) | Radioaktive embolisierende zusammensetzungen | |
HK1155944A1 (en) | W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors | |
MXPA01010588A (es) | Medicamentos que contienen de la cinasa humana regulada por el volumen celular h-sgk. | |
DE122011100032I1 (de) | Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer. | |
CU23126A3 (es) | Inhibicion de kinasa raf usando ureas heterociclicas sustituidas | |
BR0312464A (pt) | Inibidores de tirosina quinases | |
TR200003801T2 (tr) | Acı hafifletmek için deri üstü kompozisyonlar ve yöntemler | |
ES2134778T3 (es) | Bistriazenos como agentes quimioterapeuticos. | |
ATE142499T1 (de) | Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren | |
ES2164911T3 (es) | Composicion farmaceutica que contiene inhibidores de interferon gamma. | |
PE92098A1 (es) | N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo | |
BG105763A (en) | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |